Blijlevens Nicole M A, Logan Richard M, Netea Mihai G
Department of Haematology, Radboud University Medical Center, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands.
J Antimicrob Chemother. 2009 May;63 Suppl 1:i36-40. doi: 10.1093/jac/dkp081.
The treatment of patients with cancer is often accompanied by life-threatening complications caused by chemotherapy and radiotherapy. They are known to result from neutropenia, but damage to the mucosal barrier as well as the humoral and cellular immune defences play a significant role in various infectious complications and aggravate diverse inflammatory processes. The article describes the journey from febrile neutropenia to febrile mucositis in patients treated with immunocompromising therapy.
癌症患者的治疗常常伴随着化疗和放疗引发的危及生命的并发症。已知这些并发症是由中性粒细胞减少引起的,但黏膜屏障以及体液和细胞免疫防御的损伤在各种感染性并发症中起着重要作用,并加剧了各种炎症过程。本文描述了接受免疫抑制治疗的患者从发热性中性粒细胞减少到发热性黏膜炎的病程。